Prostaglandin E1 treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induced proliferative responses.
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D007674:Kidney Diseases / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D008814:Mice, Inbred NZB; D008934:Mitogens / Q000494:pharmacology; D010835:Phytohemagglutinins / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology*; D013154:Spleen / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013936:Thymidine / Q000378:metabolism
D008934:Mitogens; D010835:Phytohemagglutinins; D011458:Prostaglandins E; D013936:Thymidine